In-licensing university technology and firm innovation

Kremena Slavova

Technovation, 2023, vol. 125, issue C

Abstract: This study examines the relationship between university licensing and firm follow-on innovations in the context of therapeutic biotechnology industry. Our theoretical model bridges two research streams in the organizational learning literature—learning-by-licensing and learning-by-failure— to better understand the contingent nature of such relationship. Specifically, it contends that firms that have experienced early-stage innovation failures are better positioned to uncover new knowledge creation opportunities when exposed to the licensed-in university technology. The empirics are based on a panel dataset analysis of a sample of 190 US therapeutic biotechnology firms observed from 2003 to 2011. Our findings provide empirical support to these contentions, suggesting potential interaction effects between the mechanisms of learning-by-licensing and learning-by-failure.

Keywords: Innovation; In-licensing; Organizational learning; Therapeutic biotechnology (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S016649722300069X
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:techno:v:125:y:2023:i:c:s016649722300069x

DOI: 10.1016/j.technovation.2023.102758

Access Statistics for this article

Technovation is currently edited by Jonathan Linton

More articles in Technovation from Elsevier
Bibliographic data for series maintained by Catherine Liu ().